Products for Research Use Only
RegisterLogin

Halofuginone hydrobromide

CAT: 0026-B2610-50Size: 50 mgDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0026-B2610-50Size:50 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
Halofuginone is an an ATP-dependent inhibitor prolyl-tRNA synthetase (Ki of 18.3 nM). Halofuginone attenuates osteoarthritis (OA) by inhibition of TGF-β activity. Blocks expression of MMP2 and inhibits ECM invasion in vitro and lung metastasis by bladder cancer cells in mice. Also inhibits the development of Th17-driven autoimmunity in a mouse model of multiple sclerosis by activating the amino acid response (AAR) pathway.
Shipping Conditions
Gel Pack
Storage Conditions
-20ºC
Shelf Life
36 months

Related Products

CatalogName
B3094-50Galantamine Hydrobromide
B1824-500Arecoline hydrobromide
B1824-100Arecoline hydrobromide
B3232-5Vortioxetine Hydrobromide
B3094-10Galantamine Hydrobromide
B3232-25Vortioxetine Hydrobromide
2912-50Dextromethorphan (hydrobromide hydrate)
2270-5Pifithrin-α, Cyclic, hydrobromide
2912-100Dextromethorphan (hydrobromide hydrate)

Alternative Products

CatalogName
TBW01506Halofuginone Hydrobromide
HY-N1584A-01Halofuginone (hydrobromide)
HY-N1584AR-01Halofuginone (hydrobromide) (Standard)
1993/50Halofuginone hydrobromide 50 mg
BA2045-10Halofuginone

Popular Products